IP Library Granted Patent US 11,198,849
Granted Patent B2
US 11,198,849 · App. 14/631,816 · Granted Dec 14, 2021

Method for stem cell culture and cells derived therefrom

Inventors: Jeremy Micah Crook (Wollongong, AU); Rachel Horne (Helios, SG); Blaine Wesley Phillips (Helios, SG)
Assignee: ES CELL INTERNATIONAL PTE LTD
C12N5/0606C12N2531/00C12N2533/20C12N2533/32C12N2533/70C12N2537/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,198,849
App. No.
14/631,816
Granted
Dec 14, 2021
Kind
B2
Abstract

There is described a method of promoting the attachment, survival and/or proliferation of a stem cell in culture, the method comprising culturing a stem cell on a positively-charged support surface. There are also provided a cell composition prepared according to the method of the invention.

Claims (15)

1. A cell culture system comprising pluripotent stem cells on a positively-charged support surface essentially free of feeder cells,

wherein the pluripotent stem cells are embryonic stem cells,

wherein the pluripotent stem cells express Oct4, Tra 1-60 and SSEA4,

wherein the positively-charged support surface comprises a microcarrier, and

wherein the cell culture system maintains pluripotency of the stem cells.

2. The cell culture system of claim 1 , wherein tri-methylamine is bound to the microcarrier.

3. The cell culture system of claim 1 , wherein the microcarrier is selected from the group consisting of microcarrier beads and microparticles.

4. The cell culture system of claim 1 , further comprising an extracellular matrix component.

5. The cell culture system of claim 4 , wherein the extracellular matrix component is selected from the group consisting of elastin, fibronectin, vitronectin, tenascin, laminin, entactin, aggrecan, decorin, collagen I, collagen Ill, collagen IV, and collagen VI, biologically active fragments or variants of said proteins, or combinations thereof.

6. The cell culture system of claim 4 , wherein the extracellular matrix component is synthetically derived.

7. The cell culture system of claim 1 , wherein the pluripotent stem cells are single cells or in a cluster of two or more cells.

8. The cell culture system of claim 1 , wherein the embryonic stem cells are human embryonic stem cells.

9. The cell culture system of claim 1 , wherein the pluripotent stem cells further express TRA 1-81.

10. The cell culture system of claim 1 , wherein the pluripotent stem cells are cells of an aggregate cell culture.

11. The cell culture system of claim 1 , wherein the pluripotent stem cells are cultured for at least 7 days.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: CROOK, JEREMY MICAH; HORNE, RACHEL; PHILLIPS, BLAINE WESLEY
To: ES CELL INTERNATIONAL PTE LTD
Reel/Frame 047619/0009 →
Continuity (3)
Continuation 12307684
Provisional Application 60818780 · Jul 6, 2006
Related Publication 20160024467A1 · Jan 28, 2016
Cited By (1)
US 12,692,476